Emerging therapeutic alternatives for snakebite envenoming
保存先:
| 著者: | |
|---|---|
| フォーマット: | contribución de congreso |
| 出版日付: | 2019 |
| その他の書誌記述: | The primary treatment for snakebite envenoming remains the administration of animal-derived antivenoms. While highly effective against systemic manifestations, antivenoms present drawbacks, including the need for trained healthcare staff, limited specificity (being restricted to the venoms used in immunization), and the risk of adverse reactions. |
| 国: | Kérwá |
| 機関: | Universidad de Costa Rica |
| Repositorio: | Kérwá |
| 言語: | Inglés |
| OAI Identifier: | oai:kerwa.ucr.ac.cr:10669/104658 |
| オンライン･アクセス: | https://hdl.handle.net/10669/104658 https://doi.org/10.1016/j.toxicon.2019.06.044 |
| キーワード: | Snakebite envenoming Antivenoms Recombinant antibodies Toxin inhibitors Phospholipases A2 Metalloproteinases Nanoparticles |